Home / Contract Awards / Leidos to Help USAID Facilitate Malaria Vaccine R&D Projects; Jerry Hogge Comments

Leidos to Help USAID Facilitate Malaria Vaccine R&D Projects; Jerry Hogge Comments

LeidosLogoLeidos (NYSE: LDOS) has been awarded a potential five-year, $23.7 million contract to support the U.S. Agency for International Development‘s efforts to research and develop a vaccine against malaria.

The company said Monday it will provide scientific and management services for USAID’s Malaria Vaccine Development Program under the cost-plus-fixed-fee contract.

Jerry Hogge, Leidos health deputy group president, said the company brings decades of life sciences technology and experience to the USAID program.

Leidos said the work to occur in Frederick, Maryland, could also evaluate malaria vaccine candidates during preclinical studies and clinical and field trials.

The company’s life sciences team supports medical product R&D efforts at the National Institutes of Health and the departments of Defense and Homeland Security.

Check Also

Reports: Lockheed, DoD Reach ‘Handshake’ Deal for 141 Lot 11 F-35s

Lockheed Martin (NYSE: LMT) and the Defense Department have reached a “handshake agreement” for the company …

Stephen O’Bryan Named L3 SVP, Global Business Dev’t Head

Stephen O’Bryan, a 30-year aerospace and defense veteran, has been appointed senior vice president and chief …